AGL News and Press, agilon health inc. From 04/21/23

Preliminary Results for the year ended 31 December 2022 FDA CLEARANCE A MAJOR BREAKTHROUGH FOR PARSORTIX LIQUID BIOPS Parsortix system substantially out-performs standard of care for ovarian cancer diagnosis Prostate cancer partnership signed with Solaris Health Pipeline of op...

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and host a conference call at 4:30 PM Eastern Ti...

(NewsDirect) ANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Thomas Warner from Proactive after announcing a development partnership with BioView. The partnership will see the two firms develop to create a circulating tumour cell (CTC) HER2 assay for breast cance...

PARSORTIX POSTER PRESENTED AT AACR ANNUAL MEETING 2023 Study demonstrates the feasibility of combining IF and HER2 FISH analysis with CTCs harvested using the Parsortix system Capability to measure HER2 protein overexpression on CTCs using ANGLE's Portrait Flex assay opens up substantia...

2023-04-06 00:55:53 ET Summary agilon health hosted its 2023 investor day, with positive updates on new health system partnerships and favorable updates to 2026 targets. Post the investor day, I have further conviction on AGL's value proposition. With the CMS rates now finaliz...

Notice of Preliminary Results and Webcast GUILDFORD, SURREY / ACCESSWIRE / April 3, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its preliminary results for the year ended 31 December 2022 on Friday 21 April 2023. A virtual meeting and we...

2023-03-30 13:17:06 ET Daiichi Sankyo ( OTCPK:DSKYF ) and Belgium-based Confo Therapeutics have agreed to collaborate on the discovery of small molecule agonists against an undisclosed target associated with central nervous system diseases. Terms call for Confo to receive up t...

2023-03-30 13:05:43 ET Shares of value-based care provider agilon health ( NYSE: AGL ) lost ~14% on Thursday to mark the biggest intraday drop since March 2022, coinciding with the company’s 2023 Investor Day. More than 4.2M AGL shares have changed hands compare...

The partnership supports Holland PHO and agilon’s efforts to transform health care for seniors agilon’s Total Care Model expands to more Michigan communities through new partnership Holland PHO , a Physician-Hospital Organization, with a mission to deliver qual...

Premier Health and agilon are committed to accelerating a value-based model of care that improves quality outcomes for senior patients agilon’s Total Care Model expands to more Ohio communities through new health system partnership Premier Health today announced it will e...